Isolation of drugs active against mammalian prions using a yeast-based screening assay
10.1038/nbt855
Crossref journal-article
Springer Science and Business Media LLC
Nature Biotechnology (297)
Bibliography

Bach, S., Talarek, N., Andrieu, T., Vierfond, J.-M., Mettey, Y., Galons, H., Dormont, D., Meijer, L., Cullin, C., & Blondel, M. (2003). Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nature Biotechnology, 21(9), 1075–1081.

Authors 10
  1. Stéphane Bach (first)
  2. Nicolas Talarek (additional)
  3. Thibault Andrieu (additional)
  4. Jean-Michel Vierfond (additional)
  5. Yvette Mettey (additional)
  6. Hervé Galons (additional)
  7. Dominique Dormont (additional)
  8. Laurent Meijer (additional)
  9. Christophe Cullin (additional)
  10. Marc Blondel (additional)
References 34 Referenced 156
  1. Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144 (1982). (10.1126/science.6801762) / Science by SB Prusiner (1982)
  2. Aguzzi, A., Glatzel, M., Montrasio, F., Prinz, M. & Heppner, F.L. Interventional strategies against prion diseases. Nat. Rev. Neurosci. 2, 745–749 (2001). (10.1038/35094590) / Nat. Rev. Neurosci. by A Aguzzi (2001)
  3. Wille, H. et al. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99, 3563–3568 (2002). (10.1073/pnas.052703499) / Proc. Natl. Acad. Sci. USA by H Wille (2002)
  4. Cohen, F.E. et al. Structural clues to prion replication. Science 264, 530–531 (1994). (10.1126/science.7909169) / Science by FE Cohen (1994)
  5. Korth, C., May, B.C., Cohen, F.E. & Prusiner, S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 98, 9836–9841 (2001). (10.1073/pnas.161274798) / Proc. Natl. Acad. Sci. USA by C Korth (2001)
  6. Wickner, R.B., Edskes, H.K., Roberts, B.T., Pierce, M. & Baxa, U. Prions of yeast as epigenetic phenomena: high protein “copy number” inducing protein “silencing”. Adv. Genet. 46, 485–525 (2002). (10.1016/S0065-2660(02)46018-X) / Adv. Genet. by RB Wickner (2002)
  7. Cox, B.S. Psi, a cytoplasmic supressor of super-supressor in yeast. Heredity 20, 505–521 (1965). (10.1038/hdy.1965.65) / Heredity by BS Cox (1965)
  8. Lacroute, F. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol. 106, 519–522 (1971). (10.1128/JB.106.2.519-522.1971) / J. Bacteriol. by F Lacroute (1971)
  9. Wickner, R.B. [URE3] as an altered Ure2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566–569 (1994). (10.1126/science.7909170) / Science by RB Wickner (1994)
  10. Serio, T.R. & Lindquist, S.L. [PSI+], SUP35, and chaperones. Adv. Protein Chem. 57, 335–366 (2001). (10.1016/S0065-3233(01)57027-8) / Adv. Protein Chem. by TR Serio (2001)
  11. Couzin, J. Molecular biology. In yeast, prions' killer image doesn't apply. Science 297, 758–761 (2002). (10.1126/science.297.5582.758) / Science by J Couzin (2002)
  12. True, H.L. & Lindquist, S.L. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477–483 (2000). (10.1038/35035005) / Nature by HL True (2000)
  13. Wegrzyn, R.D., Bapat, K., Newnam, G.P., Zink, A.D. & Chernoff, Y.O. Mechanism of prion loss after Hsp104 inactivation in yeast. Mol. Cell. Biol. 21, 4656–4669 (2001). (10.1128/MCB.21.14.4656-4669.2001) / Mol. Cell. Biol. by RD Wegrzyn (2001)
  14. Eaglestone, S.S., Ruddock, L.W., Cox, B.S. & Tuite, M.F. Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI(+)] of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 97, 240–244 (2000). (10.1073/pnas.97.1.240) / Proc. Natl. Acad. Sci. USA by SS Eaglestone (2000)
  15. Ferreira, P.C., Ness, F., Edwards, S.R., Cox, B.S. & Tuite, M.F. The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol. Microbiol. 40, 1357–1369 (2001). (10.1046/j.1365-2958.2001.02478.x) / Mol. Microbiol. by PC Ferreira (2001)
  16. Jung, G. & Masison, D.C. Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr. Microbiol. 43, 7–10 (2001). (10.1007/s002840010251) / Curr. Microbiol. by G Jung (2001)
  17. Chernoff, Y.O., Lindquist, S.L., Ono, B., Inge-Vechtomov, S.G. & Liebman, S.W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268, 880–884 (1995). (10.1126/science.7754373) / Science by YO Chernoff (1995)
  18. Nishida, N. et al. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74, 320–325 (2000). (10.1128/JVI.74.1.320-325.2000) / J. Virol. by N Nishida (2000)
  19. Blondel, M. et al. Nuclear-specific degradation of Far1 is controlled by the localization of the F-box protein Cdc4. EMBO J. 19, 6085–6097 (2000). (10.1093/emboj/19.22.6085) / EMBO J. by M Blondel (2000)
  20. Tuite, M.F., Mundy, C.R. & Cox, B.S. Agents that cause a high frequency of genetic change from [psi+] to [psi-] in Saccharomyces cerevisiae. Genetics 98, 691–711 (1981). (10.1093/genetics/98.4.691) / Genetics by MF Tuite (1981)
  21. Jones, G.W., Song, Y. & Masison, D.C. Deletion of the Hsp70 chaperone gene SSB causes hypersensitivity to guanidine toxicity and curing of the [PSI(+)] prion by increasing guanidine uptake in yeast. Mol. Genet. Genomics 269, 304–311 (2003). (10.1007/s00438-003-0838-y) / Mol. Genet. Genomics by GW Jones (2003)
  22. Schlumpberger, M., Prusiner, S.B. & Herskowitz, I. Induction of distinct [URE3] yeast prion strains. Mol. Cell. Biol. 21, 7035–7046 (2001). (10.1128/MCB.21.20.7035-7046.2001) / Mol. Cell. Biol. by M Schlumpberger (2001)
  23. Fernandez-Bellot, E., Guillemet, E. & Cullin, C. The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele. EMBO J. 19, 3215–3222 (2000). (10.1093/emboj/19.13.3215) / EMBO J. by E Fernandez-Bellot (2000)
  24. Fernandez-Bellot, E. et al. The [URE3] phenotype: evidence for a soluble prion in yeast. EMBO Rep. 3, 76–81 (2002). (10.1093/embo-reports/kvf011) / EMBO Rep. by E Fernandez-Bellot (2002)
  25. Zamora, J.M., Pearce, H.L. & Beck, W.T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33, 454–462 (1988). / Mol. Pharmacol. by JM Zamora (1988)
  26. Haigh, J.C., Mackintosh, C. & Griffin, F. Viral, parasitic and prion diseases of farmed deer and bison. Rev. Sci. Tech. 21, 219–248 (2002). (10.20506/rst.21.2.1331) / Rev. Sci. Tech. by JC Haigh (2002)
  27. Jarrett, J.T. & Lansbury, P.T., Jr. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055–1058 (1993). (10.1016/0092-8674(93)90635-4) / Cell by JT Jarrett (1993)
  28. Krobitsch, S. & Lindquist, S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. USA 97, 1589–1594 (2000). (10.1073/pnas.97.4.1589) / Proc. Natl. Acad. Sci. USA by S Krobitsch (2000)
  29. Osherovich, L.Z. & Weissman, J.S. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 106, 183–194 (2001). (10.1016/S0092-8674(01)00440-8) / Cell by LZ Osherovich (2001)
  30. Meriin, A.B. et al. Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 157, 997–1004 (2002). (10.1083/jcb.200112104) / J. Cell Biol. by AB Meriin (2002)
  31. Caughey, B. & Race, R.E. Potent inhibition of scrapie-associated PrP accumulation by congo red. J. Neurochem. 59, 768–771 (1992). (10.1111/j.1471-4159.1992.tb09437.x) / J. Neurochem. by B Caughey (1992)
  32. Supattapone, S., Nguyen, H.O., Cohen, F.E., Prusiner, S.B. & Scott, M.R. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA 96, 14529–14534 (1999). (10.1073/pnas.96.25.14529) / Proc. Natl. Acad. Sci. USA by S Supattapone (1999)
  33. Guthrie, C. & Fink, G.R. Guide to Yeast Genetics and Molecular Biology, 194 (Academic Press, San Diego, California, 1991). / Guide to Yeast Genetics and Molecular Biology by C Guthrie (1991)
  34. Baudin, A., Ozier-Kalogeropoulos, O., Denouel, A., Lacroute, F. & Cullin, C. A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res. 21, 3329–3330 (1993). (10.1093/nar/21.14.3329) / Nucleic Acids Res. by A Baudin (1993)
Dates
Type When
Created 22 years ago (Aug. 8, 2003, 12:08 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 3:56 p.m.)
Indexed 1 month, 1 week ago (July 24, 2025, 7:32 a.m.)
Issued 22 years ago (Aug. 10, 2003)
Published 22 years ago (Aug. 10, 2003)
Published Online 22 years ago (Aug. 10, 2003)
Published Print 22 years ago (Sept. 1, 2003)
Funders 0

None

@article{Bach_2003, title={Isolation of drugs active against mammalian prions using a yeast-based screening assay}, volume={21}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/nbt855}, DOI={10.1038/nbt855}, number={9}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Bach, Stéphane and Talarek, Nicolas and Andrieu, Thibault and Vierfond, Jean-Michel and Mettey, Yvette and Galons, Hervé and Dormont, Dominique and Meijer, Laurent and Cullin, Christophe and Blondel, Marc}, year={2003}, month=aug, pages={1075–1081} }